Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease.

Digestive Diseases and Sciences
Gabriele StoccoAlessandro Ventura

Abstract

Inflammatory bowel disease (IBD) has been related to mutations of methylenetetrahydrofolate reductase (MTHFR), a critical enzyme in the metabolism of folate and methionine, both of which are important factors in DNA methylation and synthesis. A mutated MTHFR genotype was associated with increased toxicity of methotrexate treatment. The objective of this study was to verify, in a population of young patients with IBD, the presence of an association among mutations in the MTHFR gene, the incidence of IBD, and the risk of adverse events during the treatment with thiopurines azathioprine (AZA) or 6-mercaptopurine (6MP). Ninety-two patients with IBD were enrolled; 63 were treated with thiopurines; patients and 130 controls were genotyped for MTHFR mutations by PCR-based methods. The incidence of mutations in the MTHFR gene was not different between patients with IBD and control subjects; the mutated genotype was not associated with an increased risk of toxicity during thiopurine treatment.

References

Jan 1, 1992·European Journal of Clinical Pharmacology·L Lennard
Apr 7, 1989·Science·G B Elion
May 1, 1988·Thorax·D G MenziesI W Campbell
May 1, 1983·Archives of Internal Medicine·G F Longstreth, R Green
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·P J Bagley, J Selhub
Aug 27, 1999·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·J D WisotzkeyD Jones
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·C F SkibolaG Morgan
May 16, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G ToffoliD Crivellari
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·J L WiemelsUNKNOWN United Kingdom Childhood Cancer Study investigators
Apr 3, 2001·Trends in Pharmacological Sciences·P M UelandS E Vollset
Feb 15, 2002·Scandinavian Journal of Gastroenterology·Larsen T BjerregaardH Hey
May 29, 2002·Alimentary Pharmacology & Therapeutics·A BarabinoC Barbera
Jun 8, 2002·Pharmacogenomics·Cornelia M UlrichRachel Sparks
Oct 29, 2003·Journal of Pediatric Gastroenterology and Nutrition·Emi NakanoHilary J Powers

❮ Previous
Next ❯

Citations

Mar 14, 2012·Nature Reviews. Gastroenterology & Hepatology·Lynnette R Ferguson
Jun 30, 2011·Nature Reviews. Nephrology·Pooja Budhiraja, Mordecai Popovtzer
Jun 9, 2009·Alimentary Pharmacology & Therapeutics·M A SmithJ D Sanderson
May 6, 2015·Pediatrics International : Official Journal of the Japan Pediatric Society·Ryoko SuzukiTakashi Fukushima
Jan 22, 2015·Biomarkers in Medicine·Steven Chung Ming FongJeremy David Sanderson
Jan 21, 2010·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Elias Zintzaras
Jul 8, 2017·Pharmacogenomics·Sara RufiniPaola Borgiani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.